BALDINI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1665
EU - Europa 1364
AS - Asia 495
AF - Africa 25
OC - Oceania 23
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3596
Nazione #
US - Stati Uniti d'America 1623
DE - Germania 629
IT - Italia 367
CN - Cina 230
GB - Regno Unito 110
IN - India 68
JP - Giappone 61
FR - Francia 52
CZ - Repubblica Ceca 37
CA - Canada 33
KR - Corea 33
RU - Federazione Russa 31
AU - Australia 21
ES - Italia 18
TW - Taiwan 17
BE - Belgio 14
NL - Olanda 13
RO - Romania 12
UA - Ucraina 12
ZA - Sudafrica 11
IR - Iran 10
GR - Grecia 9
HU - Ungheria 9
TR - Turchia 9
CL - Cile 8
HK - Hong Kong 8
MX - Messico 8
TH - Thailandia 7
VN - Vietnam 7
EU - Europa 6
PK - Pakistan 6
PL - Polonia 6
SE - Svezia 6
CH - Svizzera 5
CO - Colombia 5
DK - Danimarca 5
NO - Norvegia 5
SA - Arabia Saudita 5
SG - Singapore 5
FI - Finlandia 4
IQ - Iraq 4
PT - Portogallo 4
EG - Egitto 3
ID - Indonesia 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BR - Brasile 2
BY - Bielorussia 2
CY - Cipro 2
IE - Irlanda 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LV - Lettonia 1
MK - Macedonia 1
QA - Qatar 1
SD - Sudan 1
SY - Repubblica araba siriana 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3600
Città #
Fairfield 212
Milan 145
Seattle 113
Houston 111
Santa Cruz 90
Ashburn 83
Buffalo 83
Woodbridge 83
Ann Arbor 68
Wilmington 67
Cambridge 56
Nürnberg 41
Beijing 35
Shanghai 33
Mountain View 27
Southend 26
Tianjin 23
Tokyo 20
Chicago 18
San Diego 18
Las Vegas 16
Nanjing 16
Leawood 15
Wuhan 13
Rochester 12
Toronto 12
Bengaluru 10
Milpitas 10
Provo 10
Redmond 10
Kiez 9
London 9
Phoenix 9
Taipei 9
Muizenberg 8
Ottawa 8
University Park 8
Villasanta 8
Hangzhou 7
Lake Forest 7
Miami 7
Munich 7
New Delhi 7
New York 7
Berlin 6
Chennai 6
Clearwater 6
Dearborn 6
Genova 6
North Shields 6
Seoul 6
Taichung 6
Würzburg 6
Atlanta 5
Bari 5
Bologna 5
Chengdu 5
Dallas 5
Dunstable 5
Gent 5
Los Angeles 5
Morgantown 5
Ningbo 5
Norwalk 5
Orange 5
Rome 5
Siena 5
Bangalore 4
Budapest 4
Central District 4
Fremont 4
Hamilton 4
Henderson 4
Istanbul 4
Kish 4
Napoli 4
Pavia 4
Philadelphia 4
Salamanca 4
Amsterdam 3
Ankara 3
Ashtead 3
Athens 3
Bangkok 3
Boston 3
Bribie 3
Brisbane 3
Bucharest 3
Dong Ket 3
Hebei 3
Heidelberg 3
Helsinki 3
Lacul 3
Landshut 3
Louisville 3
Manchester 3
Mcallen 3
Moscow 3
Mumbai 3
Nagoya 3
Totale 1821
Nome #
Stereotyped patterns of B-CELL receptor in splenic marginal zone lymphoma, file dfa8b98f-7ce1-748b-e053-3a05fe0a3a96 678
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation, file dfa8b992-9bb2-748b-e053-3a05fe0a3a96 443
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature, file dfa8b995-86bd-748b-e053-3a05fe0a3a96 260
Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias, file dfa8b990-630d-748b-e053-3a05fe0a3a96 237
Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia, file dfa8b990-7f80-748b-e053-3a05fe0a3a96 169
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias, file dfa8b99a-651c-748b-e053-3a05fe0a3a96 159
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias, file dfa8b992-f84d-748b-e053-3a05fe0a3a96 147
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection : a study on behalf of the Fondazione italiana linfomi, file dfa8b991-7b5f-748b-e053-3a05fe0a3a96 137
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma, file dfa8b9a7-d5c9-748b-e053-3a05fe0a3a96 131
Plasmablastic lymphoma of the stomach : a case report, file dfa8b998-1a79-748b-e053-3a05fe0a3a96 127
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia, file dfa8b99f-4d96-748b-e053-3a05fe0a3a96 127
UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia, file dfa8b99f-abdb-748b-e053-3a05fe0a3a96 112
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma, file dfa8b9a1-8a49-748b-e053-3a05fe0a3a96 89
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek, file dfa8b9a1-4020-748b-e053-3a05fe0a3a96 85
What Is New in the Treatment of Smoldering Multiple Myeloma?, file dfa8b9a5-741c-748b-e053-3a05fe0a3a96 80
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma, file dfa8b9a4-029d-748b-e053-3a05fe0a3a96 78
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects, file dfa8b9a3-41b0-748b-e053-3a05fe0a3a96 75
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy), file dfa8b9a2-c97f-748b-e053-3a05fe0a3a96 66
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study, file dfa8b9a7-77b3-748b-e053-3a05fe0a3a96 64
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma, file dfa8b9a8-5b8f-748b-e053-3a05fe0a3a96 62
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma, file dfa8b9a2-7d2d-748b-e053-3a05fe0a3a96 56
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays, file dfa8b9a5-f8f1-748b-e053-3a05fe0a3a96 49
Human recombinant interferon α-2C enhances the expression of class II HLA antigens on hairy cells, file dfa8b9a3-2379-748b-e053-3a05fe0a3a96 47
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity, file dfa8b9a8-6ecd-748b-e053-3a05fe0a3a96 45
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy, file dfa8b9a7-f6f1-748b-e053-3a05fe0a3a96 39
VAD protocol for treatment of advanced refractory multiple myeloma, file dfa8b990-7ecb-748b-e053-3a05fe0a3a96 38
New perspectives on polycythemia vera : from diagnosis to therapy, file dfa8b9a7-9bac-748b-e053-3a05fe0a3a96 38
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study, file dfa8b9a9-3f22-748b-e053-3a05fe0a3a96 33
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse, file dfa8b991-abd6-748b-e053-3a05fe0a3a96 23
The clinical and biological features of a series of immunophenotypic variant of B-CLL, file dfa8b990-6319-748b-e053-3a05fe0a3a96 15
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma, file dfa8b9a9-9eb9-748b-e053-3a05fe0a3a96 7
Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib, file dfa8b9a9-d469-748b-e053-3a05fe0a3a96 7
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort, file bbb9dbb7-242e-4d32-b176-7f28b0a0bd04 5
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response, file dfa8b99b-f6fa-748b-e053-3a05fe0a3a96 5
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial, file dfa8b99c-efcf-748b-e053-3a05fe0a3a96 5
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network, file dfa8b99f-e597-748b-e053-3a05fe0a3a96 5
Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse, file dfa8b9a2-1c88-748b-e053-3a05fe0a3a96 5
Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemia, file dfa8b990-7d0a-748b-e053-3a05fe0a3a96 4
Total body computed tomography scan in the initial work-up of binet stage a chronic lymphocytic leukemia patients : results of the prospective, multicenter o-cll1-gisl study, file dfa8b990-9900-748b-e053-3a05fe0a3a96 4
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment, file dfa8b991-735f-748b-e053-3a05fe0a3a96 4
The expression of cyclin D1 in multiple myeloma (MM) correlates with the degree of bone marrow infiltration and the clinical stage of disease, file dfa8b99a-8ef8-748b-e053-3a05fe0a3a96 4
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network, file dfa8b9a0-38f5-748b-e053-3a05fe0a3a96 4
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin, file dfa8b9a9-da2d-748b-e053-3a05fe0a3a96 4
Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia : The Gruppo Italiano Studio Linfomi (GISL) experience, file dfa8b990-5c19-748b-e053-3a05fe0a3a96 3
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia, file dfa8b991-74a5-748b-e053-3a05fe0a3a96 3
Intensity of CD 20 expression in B-cell lymphoproliferative syndromes, file dfa8b99a-8fcb-748b-e053-3a05fe0a3a96 3
Intensity of CD20 expression in B-cell lymphoproliferative syndromes, file dfa8b99a-975c-748b-e053-3a05fe0a3a96 3
Maintenance in myeloma patients achieving complete response after upfront therapy : a pooled analysis, file dfa8b99b-e832-748b-e053-3a05fe0a3a96 3
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial, file dfa8b99d-987f-748b-e053-3a05fe0a3a96 3
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach, file dfa8b99f-e598-748b-e053-3a05fe0a3a96 3
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach, file dfa8b9a0-2a3b-748b-e053-3a05fe0a3a96 3
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality, file dfa8b9a3-419b-748b-e053-3a05fe0a3a96 3
Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia, file dfa8b991-705b-748b-e053-3a05fe0a3a96 2
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era, file dfa8b991-74ed-748b-e053-3a05fe0a3a96 2
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly fit patients with diffuse large B-cell lymphoma : results from the ANZINTER3 trial of the Intergruppo italiano linfomi, file dfa8b991-75f8-748b-e053-3a05fe0a3a96 2
Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma, file dfa8b991-7a87-748b-e053-3a05fe0a3a96 2
Molecular classification of multiple myeloma: a distinct profile characterizes patients expressing CCND1 and negative for 14q32 translocations, file dfa8b992-82a3-748b-e053-3a05fe0a3a96 2
Role of CD79b and CD43 in the diagnosis of chronic B-cell lymphoproliferative syndromes, file dfa8b99a-5859-748b-e053-3a05fe0a3a96 2
Cytofluorimetric evaluation of B cell clonality in bone marrow of IgM MGUS, file dfa8b99a-6d24-748b-e053-3a05fe0a3a96 2
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series, file dfa8b9a4-b2a3-748b-e053-3a05fe0a3a96 2
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade, file 0386b360-c170-44af-bac1-e70ddb4d2619 1
Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors, file dfa8b990-5b98-748b-e053-3a05fe0a3a96 1
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy, file dfa8b991-6d8d-748b-e053-3a05fe0a3a96 1
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy, file dfa8b991-743b-748b-e053-3a05fe0a3a96 1
Immunogenetics features and genomic lesions in splenic marginal zone lymphoma, file dfa8b991-749e-748b-e053-3a05fe0a3a96 1
Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas, file dfa8b991-74a2-748b-e053-3a05fe0a3a96 1
MATILDE chemotherapy regimen for primary CNS lymphoma : results at a median follow-up of 12 years, file dfa8b991-7579-748b-e053-3a05fe0a3a96 1
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas, file dfa8b991-75ba-748b-e053-3a05fe0a3a96 1
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma : a phase III randomized study by the Fondazione italiana linfomi, file dfa8b991-763e-748b-e053-3a05fe0a3a96 1
Bendamustine salvage therapy for T cell neoplasms, file dfa8b991-77d6-748b-e053-3a05fe0a3a96 1
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion, file dfa8b991-7be4-748b-e053-3a05fe0a3a96 1
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program, file dfa8b992-ee9b-748b-e053-3a05fe0a3a96 1
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome, file dfa8b993-1cd5-748b-e053-3a05fe0a3a96 1
Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma, file dfa8b996-98c5-748b-e053-3a05fe0a3a96 1
Primary plasma cell leukemia 2.0: advances in biology and clinical management, file dfa8b996-aa44-748b-e053-3a05fe0a3a96 1
Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation, file dfa8b996-e840-748b-e053-3a05fe0a3a96 1
Angiogenesis occurs in hairy cell leukaemia (HCL) and in NOD/SCID mice transplanted with the HCL line Bonna-12, file dfa8b997-0439-748b-e053-3a05fe0a3a96 1
Low-grade MALT lymphoma involving multiple mucosal sites and bone marrow, file dfa8b998-4113-748b-e053-3a05fe0a3a96 1
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma, file dfa8b99a-9bfb-748b-e053-3a05fe0a3a96 1
Bortezomib-thalidomide-dexamethasone is superior to thalidomide- dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma, file dfa8b99b-1d7a-748b-e053-3a05fe0a3a96 1
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma, file dfa8b99c-0ec5-748b-e053-3a05fe0a3a96 1
Global methylation patterns in primary plasma cell leukemia, file dfa8b99c-74d9-748b-e053-3a05fe0a3a96 1
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients, file dfa8b9a1-4146-748b-e053-3a05fe0a3a96 1
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma, file dfa8b9a1-437f-748b-e053-3a05fe0a3a96 1
Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma, file dfa8b9a2-7b97-748b-e053-3a05fe0a3a96 1
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL), file dfa8b9a5-461b-748b-e053-3a05fe0a3a96 1
GVHD orale post-trapianto allogenico per mieloma multiplo = Oral GVHD post allogeneic transplantation for multiple myeloma, file dfa8b9a8-1df9-748b-e053-3a05fe0a3a96 1
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study, file dfa8b9a9-5840-748b-e053-3a05fe0a3a96 1
Totale 3843
Categoria #
all - tutte 4425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018185 00033 2013 1629 3215207
2018/2019377 18171524 2522 2927 31445966
2019/2020565 40294055 6452 6043 54433352
2020/2021589 25443731 6976 3668 55516433
2021/20221037 62613958 12268 10587 687020196
2022/2023251 40461650 00 00 0000
Totale 3843